D. Urankar, I. Rutar, B. Modec, D. Dolenc
(2R*,3S*)-2-Bromo-3-hydroxy-3-phenylpropanenitrile (2g): M.p. product was purified by column chromatography (silica, diethyl
FULL PAPER
1
70–72 °C. H NMR (CDCl3): δ = 2.78 (d, J = 3.9 Hz, 1 H), 4.47
(d, J = 4.3 Hz, 1 H), 5.06 (dd, J = 4.3, 3.9 Hz, 1 H), 7.26–7.46 (m,
5 H) ppm. 13C NMR (CDCl3): δ = 34.4, 75.0, 114.9, 126.4, 128.9,
ether/hexane, 1:2) and crystallized from dichloromethane/hexane,
1
M.p. 100–102 °C. H NMR (CDCl3): δ = 2.8 (br.s, 1 H), 4.45 (d,
J = 4.6 Hz, 1 H), 4.96 (d, J = 4.6 Hz, 1 H), 7.4 (m, 5 H) ppm. 13C
129.6, 137.01. IR (KBr disc): ν = 3420 (OH), 2259 (CN) cm–1. MS NMR (CDCl3): δ = 5.8, 75.5, 116.8, 126.3, 128.8, 129.4, 137.8 ppm.
˜
(m/z (%)): 227 [M + 2]+ (1), 225 [M+] (1), 129 (7), 107 (100), 79 IR (KBr disc): ν = 3417 (OH), 2250 (CN) cm–1. MS (m/z (%)): 273
˜
(52), 77 (32), 51 (15). C9H8BrNO (226.07): C 47.82, H 3.57, N 6.20;
found C 47.52, H 3.64, N 6.57.
[M]+ (1), 166 (2), 127 (8), 107 (100), 91 (20), 79 (53), 77 (37).
C9H8INO (273.07): C 39.59, H 2.95, N 5.12; found C 39.75, H
3.03, N 4.97.
trans-2-Bromo-3-hydroxycyclohexanone (2j):[40] Oil, 1H NMR
(CDCl3): δ = 1.64 (m, 1 H), 1.82 (m, 1 H), 2.08 (m, 1 H), 2.38 (m,
2 H), 2.6 (br.s, 1 H), 2,75 (m, 1 H) 4.00 (ddd, J = 3.6, 7.0, 7.5 Hz,
1 H), 4.40 (dd, J = 1.1, 7.0 Hz, 1 H) ppm. 13C NMR (CDCl3): δ =
[1] M. B. Smith, J. March, Advanced Organic Chemistry, 5th ed.;
Wiley-Interscience, New York, 2001, p. 478 and references cited
therein.
[2] D. Dolenc, M. Harej, J. Org. Chem. 2002, 67, 312–313.
[3] S. Boukhris, A. Souizi, Tetrahedron Lett. 2003, 44, 3259–3261.
[4] S. Boukhris, A. Souizi, A. Robert, Tetrahedron Lett. 1998, 39,
6281–6282.
[5] S. Cho, S. Kang, G. Keum, S. B. Kang, S. Y. Han, Y. Kim, J.
Org. Chem. 2003, 68, 180–182.
[6] See e.g. M. B. Smith, J. March, Advanced Organic Chemistry,
5th ed., Wiley-Interscience, New York, 2001, p. 520 and refer-
ences cited therein.
[7] H. Sharghi, M. M. Eskandari, Synthesis 2002, 1519–1522.
[8] M. A. Reddy, K. Surendra, N. Bhanumathi, K. R. Rao, Tetra-
hedron 2003, 59, 2363–2363.
[9] M. B. Smith, Organic Synthesis; McGraw–Hill, New York,
1994, pp. 182–183 and references cited therein.
[10] S. Cerritelli, M. Chiarini, G. Cerichelli, M. Capone, M. Marsili,
Eur. J. Org. Chem. 2004, 623–630.
[11] A. R. De Corso, B. Panunzi, M. Tingoli, Tetrahedron Lett.
2001, 42, 7245–7247.
20.1, 30.6, 38.7, 61.7, 75.2, 200.5 ppm. IR (liquid film): ν = 3439
˜
(OH), 1720 (CO) cm–1. MS (m/z (%)): 194 [M + 2]+ (1), 192 [M]+
(1), 134 (14), 113 (100), 95 (22), 71 (65), 60 (75), 43 (31).
(3R*,4R*)-4-Hydroxy-3-iodo-4-phenylbutan-2-one (3a): M.p. 63.7–
65.5 °C. H NMR (CDCl3): δ = 2.46 (s, 3 H), 3.4 (d, J = 5.2 Hz, 1
1
H), 4.71 (d, J = 8.5 Hz, 1 H), 5.10 (dd, J = 5.1, 8.5 Hz, 1 H), 7.4
(m, 5 H) ppm. 13C NMR (CDCl3): δ = 27.4, 35.5, 75.8, 127.0,
128.5, 128.6, 139.7, 203.9 ppm. IR (KBr disc): ν = 3406 (OH), 1704
˜
(CO) cm–1. MS (m/z (%)): 290 [M]+ (0.5), 230 (14), 184 (100), 163
(38), 107 (72), 105 (20), 103 (39), 91 (23), 79 (47), 77 (45).
C10H11IO2 (290.10): C 41.40, H 3.82; found C 41.40, H 3.65.
(2R*,3R*)-3-Hydroxy-2-iodo-1,3-diphenylpropan-1-one (3b): M.p.
122–124 °C. 1H NMR (CDCl3): δ = 3.8 (br.s, 1 H), 5.36 (d, J =
8.0 Hz, 1 H), 5.54 (d, J = 8.0 Hz, 1 H), 7.3–7.6 (m, 8 H), 8.0 (m,
2 H) ppm. 13C NMR (CDCl3): δ = 29.1, 76.0, 127.2, 128.46, 128.52,
128.73, 128.78, 134.0, 134.2, 139.9, 196.1 ppm. IR (KBr disc): ν =
˜
3482 (OH), 1661 (CO) cm–1. MS (m/z (%)): 246 (82), 225 (30), 207
(19), 105 (100), 91 (19), 77 (72). C15H13IO2 (352.17): C 51.16, H
3.72; found C 51.03, H 3.77.
[12] B. F. Sels, D. E. De Vos, P. A. Jacobs, J. Am. Chem. Soc. 2001,
123, 8350–8359.
[13] J. Barluenga, M. Marco-Arias, F. Gonzalez-Bobes, A. Bal-
lestros, J. M. Gonzalez, Chem. Eur. J. 2004, 10, 1677–1682.
[14] N. S. Zefirov, G. A. Sereda, S. E. Sosonuk, N. V. Zyk, T. I. Li-
khomanova, Synthesis 1995, 1359–1361.
[15] J. Barluenga, Pure Appl. Chem. 1999, 71, 431–436.
[16] H. Masuda, K. Takase, M. Nishio, A. Hasegawa, Y. Nishi-
yama, Y. Ishii, J. Org. Chem. 1994, 59, 5550.
[17] S. Raghavan, S. R. Reddy, K. A. Tony, C. N. Kumar, A. K.
Varma, A. Nangia, J. Org. Chem. 2002, 67, 5838–5841.
[18] S. A. Boyes, A. T. Hewson, J. Chem. Soc. Perkin Trans. 1 2000,
2759–2765.
(2R*,3R*)-2-Iodo-3-methoxy-1,3-diphenylpropan-1-one
(3c):
M.p.86–87 °C (lit.[28] 96 °C). H NMR (CDCl3): δ = 3.20 (s, 3 H),
4.90 (d, J = 10.1 Hz, 1 H), 5.39 (d, J = 10.1 Hz, 1 H), 7.3–7.6 (m,
8 H), 8.0–8.1 (m, 2 H) ppm. 13C NMR (CDCl3): δ = 28.6, 58.0,
84.2, 128.27, 128.30, 128.67, 128.75, 128.80, 133.5, 134.8, 138.5,
194.2 ppm. MS (m/z (%)): 366 [M]+(0.1), 239 (64), 230 (18), 223
(24), 207 (25), 121 (59), 105 (100), 103 (35), 91 (31), 77 (88).
1
(2R*,3R*)-3-Ethoxy-2-iodo-1,3-diphenylpropan-1-one (3d): M.p.
97–99 °C (lit.[28] 75–76 °C). 1H NMR (CDCl3): δ = 0.98 (t, J =
7.0 Hz, 3 H), 3.38 (m, 2 H), 5.00 (d, J = 10.2 Hz, 1 H), 5.37 (d, 1
H, J = 10.2 Hz, 1 H), 7.3–7.6 (m, 8 H), 8.0–8.1 (m, 2 H) ppm. 13C
NMR (CDCl3): δ = 15.1, 29.2, 65.9, 82.6, 128.2, 128.6, 128.7, 133.4,
135.0, 139.3, 194.1 ppm.
[19] R. Rodebaugh, B. Fraser-Reid, Tetrahedron 1996, 52, 7663–
7678.
[20] Y. Guindon, B. Guérin, C. Chabot, W. Ogilvie, J. Am. Chem.
Soc. 1996, 118, 12528–12535.
[21] S. P. L. de Souza, J. F. M. da Silva, M. C. S. de Mattos, J. Braz.
Chem. Soc. 2003, 14, 832–835.
[22] M. Smietana, V. Gouverneur, C. Mioskowski, Tetrahedron
Lett. 2000, 41, 193–195.
(2R*,3R*)-3-Hydroxy-2-iodo-3-phenylpropanoic Acid (3e): Isolation
1
procedure: see 2e. M.p. 136–138 °C (lit.[41] 141–142 °C). H NMR
([D6]acetone):[14] δ = 4.54 (d, J = 9.7 Hz, 1 H), 5.06 (d, J = 9.7 Hz,
1 H), 7.3–7.5 (m, 5 H) ppm. 13C NMR ([D6]acetone): δ = 27.2,
76.8, 128.3, 128.91, 128.93, 142.2, 171.9 ppm.
[23] D. Dolenc, Synlett 2000, 544–546.
[24] M. Aloui, A. J. Fairbanks, Synlett 2001, 797–799.
[25] D. Dolenc, Synthetic Commun. 2003, 33, 2917–2924.
[26] Although the “erythro/threo” designation is out-of-date and
imprecise, in this case all products of the anti addition to (E)-
alkenes have erythro configurations. The more precise like/un-
like or (R*,S*) notation is compound-specific and it yields dif-
ferent relative configurations for the products of reactions of
equal stereochemical course. For the original discussion on the
like/unlike stereochemical descriptors see: D. Seebach, V. Pre-
log, Angew. Chem. Int. Ed. Engl. 1982, 21, 654–660.
[27] With long reaction times in acetone as a solvent, the excess of
the reagent was consumed and a product with lachrimatory
vapours appeared. This was not investigated further, but most
probably a haloacetone was formed.
Methyl (2R*,3R*)-3-Hydroxy-2-iodo-3-phenylpropanoate (3f): M.p.
1
60–62 °C. H NMR (CDCl3): δ = 3.4 (d, J = 5.8 Hz, 1 H), 3.77 (s,
3 H), 4.58 (d, J = 8.3 Hz, 1 H), 5.09 (dd, J = 5.8, 8.3 Hz, 1 H), 7.4
(m, 5 H) ppm. 13C NMR (CDCl3): δ = 24.9, 53.5, 76.7, 127.4,
129.0, 129.2, 139.8, 172.1 ppm. IR (KBr disc): ν = 3441 (OH), 1710
˜
(CO). MS (m/z (%)): 306 [M]+ (4), 200 (78), 179 (10), 168 (15), 107
(100), 91 (32), 79 (50), 77 (41). C10H13IO3 (308.12): C 39.24, H
3.62; found C 39.24, H 3.44.
(2R*,3S*)-3-Hydroxy-2-iodo-3-phenylpropanenitrile (3g): The reac-
tion was conducted for 5 days at approx. 40 °C with a 20% excess
of NISac, until the conversion of starting nitrile reached 60%. The
2352
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 2349–2353